It has also been proposed that IL-37 can reduce Con-A-induced hepatitis by inhibiting the activity of DCs, blocking the biological effect of CD4+ T cells, increasing the proportion of Tregs and enhancing their function [33]. The gene discussed is IL37; the disease is hepatitis A virus infection.